Fidarestat
| CAS No. | 136087-85-9 | Cat. No. | BCP07501 |
| Name | Fidarestat | ||
| Synonyms | SNK860; SNK-860; SNK 860; SK860; SK-860; SK 860; | ||
| Formula | C12H10FN3O4 | M. Wt | 279.22 |
| Description | Fidarestat, also known as SNK-860 and SK-860, is a potent and promising Aldose Reductase Inhibitor. Administration of fidarestat after breakfast was effective in significantly alleviating some symptoms of diabetic polyneuropathy. Long-term treatment with SNK-860 has a beneficial preventive effect on the development of experimental diabetic neuropathy. Fidarestat is also a Promising Drug Targeting Autophagy in Colorectal Carcinoma. | ||
| Pathways | Protease/Metabolic Enzyme | ||
| Targets | Aldose Reductase | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.